Skip Navigation



Carcinogenesis Advance Access published online on August 3, 2007

Carcinogenesis, doi:10.1093/carcin/bgm178
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
28/12/2459    most recent
bgm178v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sato, H.
Right arrow Articles by Shinomura, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sato, H.
Right arrow Articles by Shinomura, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors

Hironobu Sato1,6, Hiromu Suzuki1,2,6,*, Minoru Toyota1,3,4,*, Masanori Nojima1,2, Reo Maruyama1, Shigeru Sasaki1, Hideyasu Takagi1, Yohei Sogabe3, Yasushi Sasaki3, Masashi Idogawa3, Tomoko Sonoda2, Mitsuru Mori2, Kohzoh Imai5, Takashi Tokino3 and Yasuhisa Shinomura1

1 First Department of Internal Medicine, Sapporo Medical University, Sapporo, 060-8543, Japan
2 Department of Public Health, Sapporo Medical University, Sapporo, 060-8556, Japan
3 Department of Molecular Biology, Cancer Research Institute, Sapporo Medical University, Sapporo, 060-8556, Japan
4 PRESTO JST, Kawaguchi, 332-0012, Japan
5 Sapporo Medical University, Sapporo, 060-8556, Japan

* Correspondence: Hiromu Suzuki or Minoru Toyota, First Department of Internal Medicine, Sapporo Medical University, S1, W16, Chuo-Ku, Sapporo, 060-8543, Japan, Tel: +81-11-611-2111 (Ext 3211), Fax: +81-11-618-3313, E-mail: hsuzuki{at}sapmed.ac.jp or mtoyota{at}sapmed.ac.jp

Activation of Wnt signaling has been implicated in tumorigenesis, and epigenetic silencing of Wnt antagonist genes has been detected in various cancers. In the present study, we examined the expression and methylation of DICKKOPF (DKK) family genes in gastrointestinal cancer cell lines. We found that all known DKK genes are frequently silenced in CRC cells (DKK1, 3/9, 33%; DKK2, 8/9, 89%; DKK3, 5/9, 56%; DKK4, 5/9, 56%), but not in normal colon mucosa. DKK1, -2 and -3 have 5' CpG islands, and show an inverse relation between expression and methylation. DKK methylation also was frequently observed in gastric cancer (GC) cell lines (DKK1, 6/16, 38%; DKK2, 15/16, 94%; DKK3, 10/16, 63%), but was seen less frequently in hepatocellular carcinoma (HCC) and pancreatic cancer cell lines. DKKs also were frequently methylated in primary CRCs (DKK1, 7/58, 12%; DKK2, 45/58, 78%; DKK3, 12/58, 21%) and GCs (DKK1, 15/31, 48%; DKK2, 26/31, 84%; DKK3, 12/31, 39%). Against a background of CTNNB1 or APC mutations, Dkks were less effective inhibitors of Wnt signaling than SFRPs, though overexpression of Dkks suppressed colony formation of CRC cells with such mutations. Our results demonstrate that DKKs are frequent targets of epigenetic silencing in gastrointestinal tumors, and that loss of DKKs may facilitate tumorigenesis through ß-catenin/TCF independent mechanisms.

Key Words: DKK • methylation • colorectal cancer • gastric cancer • Wnt signaling


6 These authors contributed equally to this work.

Received March 25, 2007; revised July 20, 2007; accepted July 25, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
H. Hirata, Y. Hinoda, K. Nakajima, K. Kawamoto, N. Kikuno, K. Kawakami, S. Yamamura, K. Ueno, S. Majid, S. Saini, et al.
Wnt Antagonist Gene DKK2 Is Epigenetically Silenced and Inhibits Renal Cancer Progression through Apoptotic and Cell Cycle Pathways
Clin. Cancer Res., September 15, 2009; 15(18): 5678 - 5687.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. L. Sheng, G. Huang, B. Yu, and W. X. Qin
Clinical Significance and Prognostic Value of Serum Dickkopf-1 Concentrations in Patients with Lung Cancer
Clin. Chem., September 1, 2009; 55(9): 1656 - 1664.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Toyota, H. Suzuki, Y. Sasaki, R. Maruyama, K. Imai, Y. Shinomura, and T. Tokino
Epigenetic Silencing of MicroRNA-34b/c and B-Cell Translocation Gene 4 Is Associated with CpG Island Methylation in Colorectal Cancer
Cancer Res., June 1, 2008; 68(11): 4123 - 4132.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W. Yue, Q. Sun, S. Dacic, R. J. Landreneau, J. M. Siegfried, J. Yu, and L. Zhang
Downregulation of Dkk3 activates {beta}-catenin/TCF-4 signaling in lung cancer
Carcinogenesis, January 1, 2008; 29(1): 84 - 92.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.